Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Multiple Sclerosis, Relapsing-Remitting × Natalizumab × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Multiple Sclerosis, Relapsing-Remitting 1 Multiple Sclerosis 1 Melanoma 1 Carcinoma, Basal Cell 1

Interventions

teriflunomide 1 Natalizumab 1 Interferon beta-1b 1 Fingolimod Hydrochloride 1 Dimethyl Fumarate 1 Alemtuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06705608 2024-11-26

MS; FTY720

University of British Columbia

Carcinoma, Basal Cell, Melanoma, Multiple Sclerosis, Skin Neoplasms, Multiple Sclerosis, Relapsing-Remitting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡